10.1245/s10434-016-5614-4 50 HadamitzkyC.ZaitsevaT
Los efectos de los AgGLP-1 sobre la obesidad, la resistencia insulnica, la inflamacin, la apnea del sueo y otros FRCV posicionan favorablemente a este grupo de frmacos para el tratamiento del sndrome del ovario poliqustico y de la infertilidad asociada a obesidad35
Oral semaglutide induces loss of body fat mass without affecting muscle mass in patients with type 2 diabetes
Godoi, A
Heres the honest truthwhat is covered now, potential changes, what GLP-1s do, the pros & cons, and why for many, diet + exercise are still powerful, safer tools
Results Across mechanistic endpoints, LC was associated with reductions in inflammatory markers, oxidative stress indices, and cardiac injury biomarkers, with several trials noting improvements in left-ventricular function and lipid profiles